|
Results of Annual General Meeting
25 November 2008
Chairman's Address to Shareholders
25 November 2008
Annual General Meeting Presentation
25 November 2008
Notice of Annual General Meeting
and Proxy Form
22 October 2008
Preliminary Final Report and Financial Statements
25 August 2008
DuPont and Hexima Partner to Develop and Commercialize Fungal Disease Resistance Technology
7 August 2008
Hexima Announces More Successful Field Trials
31 July 2008
Hexima Board Appointments
30 June 2008
Hexima Announces Successful Field Trials
20 June 2008
Appointment of Chief Executive Officer
24 April 2008
Research appointment 8 February 2008
Important steps forward in
Fungal Resistance Program
31 January 2008
Field trial update
30 January 2008
Appendix 3B – New Issue Announcement
11 January 2008
Company secretary appointment
9 January 2008
|
